NASDAQ: STAA
STAAR Surgical Company
Healthcare · Medical - Instruments & Supplies
Market Cap
$1.45B
52w High
$35.87
52w Low
$15.59
P/E
-69.10
Volume
739.65K
Outstanding Shares
49.79M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 72.82% over the last year. Revenue grew 4.03% over the trailing twelve months. Operating margin moved from -24.26% to -1.72%. Free cash flow declined 301.94% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -1.72%. A decisive move in revenue — currently up 4.03% — would be the clearest signal to resolve the ambiguity.
Company profile
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation.
Valuation
Stock splits
Every 2 shares became 1
Every 2 shares became 1
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
4
Buy
10
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 12, 2026
Q3 FY26 · EPS est $0.21 · Revenue est $90.17M
View